18F-FES PET/CT in Imaging Patients with Desmoid Tumors

This pilot clinical trial studies fluorine (F)-18 16 alpha-fluoroestradiol (18F-FES) positron emission tomography (PET)/computed tomography (CT) imaging in patients with desmoid tumors. 18F-FES binds to estrogen receptors, which are variably present on desmoid tumors, and gives off radiation that may be detected by PET/CT scans. The PET/CT scan forms an image that may show where tumor cells with estrogen receptors are in the body.

Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT02374931.

Trial PhaseNo phase specified

Trial Typediagnostic

Lead OrganizationVanderbilt University/Ingram Cancer Center

Principal InvestigatorKatherine Hartley

• Primary IDVICC SAR 1458
• Secondary IDsNCI-2015-00081
• ClinicalTrials.gov IDNCT02374931